Multiple massive wildfires are raging in Los Angeles, blanketing the surrounding regions under a pungent haze caused by smoke ...

Fintel reports that on January 10, 2025, Needham upgraded their outlook for Collegium Pharmaceutical (NasdaqGS:COLL) from ...

Johnson & Johnson stock (NYSE: JNJ) lost about 7% in 2024, underperforming the broader S&P 500 index, which gained 23% for ...

The industry is set to make notable progress in cutting-edge areas such as CAR-T cell therapy, mRNA vaccines, and the ...

Fintel reports that on January 8, 2025, Citigroup initiated coverage of West Pharmaceutical Services (NYSE:WST) with a Buy ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Avadel Pharmaceuticals (AVDL – Research Report) ...

About ADARx Pharmaceuticals ADARx Pharmaceuticals, Inc. is a late-stage clinical biotechnology company dedicated to transforming cutting-edge science into next-generation RNA medicines across a wide ...

Following acceptance of a protocol amendment, Rhythm expects to begin dosing patients with acquired HO in Part C of the Phase ...

Based on the one-year price targets offered by 10 analysts, the average target price for Avadel Pharmaceuticals PLC (NASDAQ:AVDL) is $23.30 with a high estimate of $27.00 and a low estimate of $20.00.

Whales with a lot of money to spend have taken a noticeably bullish stance on Regeneron Pharmaceuticals. Looking at options history for Regeneron Pharmaceuticals (NASDAQ:REGN) we detected 10 trades.

Healthcare has been one of Jim Cramer’s favorite topics lately. The tail end of the year has pushed a portion of the sector, ...

The widespread use of pharmaceuticals in America is introducing even more toxic “forever chemicals” into the environment ...